The provided information describes a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Moderna US, Inc. The contract, valued at up to $240,548,000, is for the delivery of COVID-19 pediatric vaccines over a period ending May 31, 2025.
Moderna US, Inc., a subsidiary of Modernatx, Inc., is a biotechnology company that specializes in messenger RNA (mRNA) therapeutics and vaccines. The company has received multiple federal contract awards to supply COVID-19 mRNA vaccines, including definitive contracts from the Department of Health and Human Services and the Department of the Army. In addition to the current IDC with the CDC, Moderna also holds a separate IDC with the CDC to provide adult COVID-19 vaccines, valued at over $400 million.
Generated 9/7/24, 9:13 AM